about
Liver transplantation for viral hepatitis in 2015Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?Impact of new treatment options for hepatitis C virus infection in liver transplantationHepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant MedicineBone marrow derived stem cells for the treatment of end-stage liver diseaseSuccinct guide to liver transplantation for medical studentsA novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmissionFeasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsHepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantationSafety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation.Fluorescence lifetime imaging of alterations to cellular metabolism by domain 2 of the hepatitis C virus core protein.Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WESynergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.Genetic polymorphism of interferon regulatory factor 5 (IRF5) correlates with allograft acute rejection of liver transplantation.High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody.Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.Novel mechanism of arenavirus-induced liver pathology.Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 CellsEfficacy and safety of sofosbuvir-based interferon-free therapies for hepatitis C in liver transplant recipients.Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virusHuman monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.New perspectives for preventing hepatitis C virus liver graft infection.Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils.Novel therapies for hepatitis C - one pill fits all?Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.Tissue-resident T cells, in situ immunity and transplantation.HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infectionEfficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents.Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation.Advances in hepatitis C therapies.Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view.Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
P2860
Q26773224-2FE0CB39-BD9A-4E38-9712-E766B71C0906Q26781880-BCA41A03-CBBF-4317-8BE7-1C9ED6D9BD0FQ26782017-71F17C42-0222-47B6-B568-1B5F876ABD83Q26801198-12510545-96A0-442E-BF50-A9E34E7EA9D0Q26850412-8A4C80F2-DB3C-4B83-BB33-A70E62B0D92EQ28075352-DCFB9D59-5B82-4CEE-81E5-5F39AA8F817FQ28488372-FABBC1F0-524C-4EA3-A903-3547A082DC54Q28535042-9C32E1F0-23E9-43F6-9979-88365E506D58Q30456435-F674E1F1-7053-49A9-9626-8E3D5C64D34CQ30560759-7BA4F38B-E49C-40F4-9270-DA59B5BAD36BQ33810155-A4D9F17C-BA6A-45F1-92D6-7210B4E2E06DQ34339626-406A5656-1203-4D85-9006-DA923ED939D5Q34795900-286FD732-CCDD-4BC1-8F17-07904F741BA6Q35022356-040FEAFB-D1B0-4821-8582-A0F8537635B9Q35135565-B484CD3E-C05D-4A2C-81DE-4332CA5A4464Q35161570-660FA291-8C40-4007-8D3D-C4D2EFE847D0Q35193285-849CCF7E-C5EE-463E-8107-61C1ABAEAAC5Q35228316-DE5AFF96-956A-47FB-8BD1-4E4C26F7C3F4Q35230745-771B0448-FCB2-4278-BDC6-F33A054FB96AQ35270256-3E69203E-D27C-41DA-8BD4-A2AE9C6EBD34Q35695028-09DC723E-C66B-4AD5-AFEF-CA758B140E72Q36165389-1127727C-403A-402A-839C-1731C4EA6EBCQ36650834-1431BB0B-46CE-43FD-9B8A-C2F7B0A47277Q36745425-74D0BF6A-E61C-449E-9A14-766F5431AEBEQ37015805-548DE266-08EE-408E-AA6C-7A88E5F1A69EQ37098646-77717E52-9846-4E67-BCE3-CE9A0E0AEC7CQ37253282-D9C12A65-A003-4F9C-AFA9-FC5DD1A4ECF5Q38117549-5DFAAA9C-7FE3-4B0E-B0FB-CB2E13235BA1Q38137989-73861C71-51DC-41EB-A81F-D776FCB027ECQ38187175-A67BBE0F-8FFB-4013-A90D-8F2F4B78F3AFQ38218762-02302168-8756-40F8-9A35-7371B4E71E1DQ38282854-818BD0BE-B9A1-4420-AF25-778EE4059BEFQ38384095-13F6F4AD-3999-4318-B214-BAA169B4D7D3Q38408888-A47ADF5D-3D31-4875-90E9-CCB4FC7B74B3Q38439220-0E0DE614-7E10-4B7D-87B3-1DF45B79F2B2Q38556401-6D865C59-ABE4-4C73-99E7-ABCAB4DD59B8Q38653173-D0EDCD33-0755-4886-889E-CA588300B96EQ38786027-A5622088-87D0-4A3A-8807-4F8D494FC3B4Q38850319-00FFB370-6A03-4E3A-B73B-993F7107EA0DQ38859081-4AB5B6BD-D59E-494F-8C1E-2FC9CC68571B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Viral hepatitis in liver transplantation.
@en
type
label
Viral hepatitis in liver transplantation.
@en
prefLabel
Viral hepatitis in liver transplantation.
@en
P2093
P1433
P1476
Viral hepatitis in liver transplantation.
@en
P2093
Gonzalo Crespo
Miquel Navasa
Xavier Forns
Zoe Mariño
P304
1373-1383.e1
P356
10.1053/J.GASTRO.2012.02.011
P407
P577
2012-05-01T00:00:00Z